The Division of Imaging Research at Rhode Island Hospital was established in 1990 and has successfully completed both federally-funded and industry-sponsored research trials
The division has participated in 10 federally-funded cancer imaging trials through the National Cancer Institute (NCI) and ECOG-ACRIN. These trials include screening studies and studies looking at the efficacy of various imaging modalities.
The division has participated in studies with pharmaceutical companies on phase I, II, and III trials. These studies include both diagnostic and cancer treatment drugs. We have also worked with various device manufacturers that are seeking pre-market and post-market Food and Drug Administration approval for medical devices. In addition, we have participated in several blood biomarker studies. We have extensive experience working with various clinical research organizations and are adept with both paper and electronic data submission.
The division is academically affiliated with the Warren Alpert Medical School of Brown University. Also, the physicians in our department that serve as study investigators have a long standing working relationship with all the physicians in our facility. These relationships strengthen our enrollment efforts and provide the Division of Imaging Research with the unique opportunity to offer various patient populations in the community a broad range of research trials.
Top Accruing Institution for Thoracic Trials
During the ACOSOG Semi-Annual Meeting, March 24-27, 2010 in Chicago. We were recognized as the "Top Accruing Institution for Thoracic Trials" within ACOSOG. We have enrolled the largest group of subjects in ACOSOG Z4033- entitled "Radiofrequency Ablation in Treating Patients With Stage I Non-Small Cell Lung Cancer."